Cipher Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cipher Pharmaceuticals with three other
companies in this sector in CANADA :
Harvest One Cannabis Inc
sales of 8.38 million Canadian Dollars [US$6.57 million]
of which 93%
Polydex Pharmaceuticals Limited
(6.81 million Canadian Dollars [US$5.33 million]
Valeo Pharma Inc
(7.47 million Canadian Dollars [US$5.85 million]
of which 100%
was Single segment).
During the second
quarter of 2021, sales at Cipher Pharmaceuticals totalled
an increase of 15.9%
from the C$6.48 million in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled C$14.42 million, which is
than through the first two quarters of 2020.
Cipher Pharmaceuticals reported sales of C$28.94 million (US$22.66 million)
December of 2020.
decrease of 2.6%
versus 2019, when the company's sales were C$29.71 million.